Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review

• Published in: PloS one Vol. 15; no. 11; p. e0241955
• Main Authors: Izcovich, Ariel, Ragusa, Martín Alberto, Tortosa, Fernando, Lavena Marzio, María Andrea, Agnoletti, Camila, Bengolea, Agustín, Ceirano, Agustina, Espinosa, Federico, Saavedra, Ezequiel, Sanguine, Verónica, Tassara, Alfredo, Cid, Candelaria, Catalano, Hugo Norberto, Agarwal, Arnav, Foroutan, Farid, Rada, Gabriel
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 17-11-2020; Public Library of Science (PLoS)
• Subjects: Aged; Aging; Albumins; Anorexia; Arrhythmia; Arthralgia; Aspartate aminotransferase; Betacoronavirus; Bias; Bilirubin; Biology and Life Sciences; Blood pressure; Brain natriuretic peptide; C-reactive protein; Cardiovascular diseases; Care and treatment; Cell number; Cerebrovascular diseases; Chronic obstructive pulmonary disease; Clinical trials; Comorbidity; Coronary artery disease; Coronavirus Infections - epidemiology; Coronavirus Infections - mortality; Coronaviruses; COVID-19; Creatine; Creatine kinase; Creatinine; Data Management; Decision making; Dementia disorders; Diabetes mellitus; Dimers; Dyspnea; Eating disorders; Erythrocytes; Fatalities; Female; Fever; Health risks; Heart diseases; Hospitals; Humans; Hypertension; Hypoxemia; Infectious diseases; Interleukin 6; Kidney diseases; Kinases; Lactate dehydrogenase; Leukocytes; Lung diseases; Lymphocytes; Male; Medical prognosis; Medicine and Health Sciences; Metabolic disorders; Middle Aged; Mortality; Pain; Pandemics; Patient outcomes; Pneumonia, Viral - epidemiology; Pneumonia, Viral - mortality; Prognosis; Protocol (computers); Public health; Research and Analysis Methods; Respiration; Respiratory distress syndrome; Respiratory failure; Risk assessment; Risk Factors; SARS-CoV-2; Searching; Sensitivity analysis; Severe acute respiratory syndrome coronavirus 2; Socioeconomic Factors; Systematic review; Tachycardia; Tachypnea; Urea; Chile; Canada; Argentina
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0241955

The objective of our systematic review is to identify prognostic factors that may be used in decision-making related to the care of patients infected with COVID-19.
We conducted highly sensitive searches in PubMed/MEDLINE, the Cochrane Central Register of Controlled Trials (CENTRAL) and Embase. The searches covered the period from the inception date of each database until April 28, 2020. No study design, publication status or language restriction were applied.
We included studies that assessed patients with confirmed or suspected SARS-CoV-2 infectious disease and examined one or more prognostic factors for mortality or disease severity. Reviewers working in pairs independently screened studies for eligibility, extracted data and assessed the risk of bias. We performed meta-analyses and used GRADE to assess the certainty of the evidence for each prognostic factor and outcome.
We included 207 studies and found high or moderate certainty that the following 49 variables provide valuable prognostic information on mortality and/or severe disease in patients with COVID-19 infectious disease: Demographic factors (age, male sex, smoking), patient history factors (comorbidities, cerebrovascular disease, chronic obstructive pulmonary disease, chronic kidney disease, cardiovascular disease, cardiac arrhythmia, arterial hypertension, diabetes, dementia, cancer and dyslipidemia), physical examination factors (respiratory failure, low blood pressure, hypoxemia, tachycardia, dyspnea, anorexia, tachypnea, haemoptysis, abdominal pain, fatigue, fever and myalgia or arthralgia), laboratory factors (high blood procalcitonin, myocardial injury markers, high blood White Blood Cell count (WBC), high blood lactate, low blood platelet count, plasma creatinine increase, high blood D-dimer, high blood lactate dehydrogenase (LDH), high blood C-reactive protein (CRP), decrease in lymphocyte count, high blood aspartate aminotransferase (AST), decrease in blood albumin, high blood interleukin-6 (IL-6), high blood neutrophil count, high blood B-type natriuretic peptide (BNP), high blood urea nitrogen (BUN), high blood creatine kinase (CK), high blood bilirubin and high erythrocyte sedimentation rate (ESR)), radiological factors (consolidative infiltrate and pleural effusion) and high SOFA score (sequential organ failure assessment score).
Identified prognostic factors can help clinicians and policy makers in tailoring management strategies for patients with COVID-19 infectious disease while researchers can utilise our findings to develop multivariable prognostic models that could eventually facilitate decision-making and improve patient important outcomes.
Prospero registration number: CRD42020178802. Protocol available at: https://www.medrxiv.org/content/10.1101/2020.04.08.20056598v1.